Riga, Latvia – 25 September, 2012. URALCHEM and a leading charitable organization of Latvia, the Ziedot.lv Foundation, have agreed to cooperate to help physically challenged children who need specific treatment or rehabilitation in leading Russian clinics. URALCHEM will provide funding for the hospitalization and treatment of children to the amount of 80 thousand Euros. A corresponding agreement has been signed today by URALCHEM CEO Dmitry Konyaev and Manager of the Ziedot.lv Foundation Ruta Dimanta.
Dmitry Konyaev, CEO of URALCHEM, OJSC:
“URALCHEM has been implementing a large-scale logistics project involving the creation of a terminal for transhipment of mineral fertilizers in the Latvian port of Riga since 2009. Traditionally, in all regions where URALCHEM does business, we pursue a socially responsible policy, which aims to address the socio-economic problems of population of these regions. Helping children has always been one of the priorities of our policy . In a joint program with Ziedot.lv we will help families of different nationalities living in Latvia who need financial and medical support. “
Ruta Dimanta, Head of the Fund Ziedot.lv:
"The programme will help physically challenged children who need treatment in Russian clinics, and whose families are not able to cover all the costs. URALCHEM’s support is particularly important because the treatment of Latvian residents outside the European Union is not funded by the state. In practice, in cases with rare or complex diseases, it is necessary to seek help outside Latvia. Children deserve to have the highest level of treatment based on modern scientific developments. "
The agreement stipulates that, within a specially designed charity programme - “Help for physically challenged children", 20 children from Latvia will be treated in leading medical institutions in Russia during the coming year. The programme participants are selected by the fund Ziedot.lv on the basis of physician's recommendations and parents’ requests for financial assistance. Assistance is needed in the treatment of diseases such as autism, vision recovery, cerebral palsy and developmental delay.
With this initiative by URALCHEM, Latvian children will now be able to access world leading medical treatment not only within the EU but in Russia as well.